What Does Atrial Fibrillation Mean in Patients With Cardiac Implantable Electronic Devices?
作者信息
Uhm Jae-Sun
机构信息
Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
出版信息
Korean Circ J. 2024 Jan;54(1):28-29. doi: 10.4070/kcj.2023.0302.
Abstract
摘要
相似文献
1
What Does Atrial Fibrillation Mean in Patients With Cardiac Implantable Electronic Devices?心脏植入式电子设备患者的心房颤动意味着什么？
Korean Circ J. 2024 Jan;54(1):28-29. doi: 10.4070/kcj.2023.0302.
2
Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices.心脏植入式电子设备检测到的心房颤动的临床意义。
Heart Rhythm. 2014 Apr;11(4):719-24. doi: 10.1016/j.hrthm.2014.01.001. Epub 2014 Jan 3.
3
Atrial high rate episodes in patients with dual-chamber cardiac implantable electronic devices: unmasking silent atrial fibrillation.双腔心脏植入式电子设备患者的房性高频率发作：揭示隐匿性心房颤动
Pacing Clin Electrophysiol. 2014 Aug;37(8):1080-6. doi: 10.1111/pace.12428. Epub 2014 May 30.
4
Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.心脏植入式电子设备患者中与心房高频率发作相关的无症状性缺血性脑损伤。
Europace. 2015 Mar;17(3):364-9. doi: 10.1093/europace/euu267. Epub 2014 Oct 21.
5
Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices.心房颤动负担、进展与死亡风险：心脏植入式电子设备患者的病例交叉分析。
Europace. 2019 Mar 1;21(3):404-413. doi: 10.1093/europace/euy222.
6
Long-term monitoring to detect atrial fibrillation with the indwelling implantable cardiac monitors.使用植入式心脏监测器进行长期监测以检测心房颤动。
Int J Stroke. 2018 Dec;13(9):893-904. doi: 10.1177/1747493018790023. Epub 2018 Aug 9.
7
Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices.心脏植入式电子设备检测心房颤动的方法、准确性及临床意义
Int J Cardiol. 2017 Jun 1;236:262-269. doi: 10.1016/j.ijcard.2016.12.189. Epub 2017 Jan 14.
8
Assessing Interplay Between Atrial Fibrillation and Heart Failure in Patients With Cardiac Implantable Electronic Devices.评估心脏植入式电子设备患者心房颤动与心力衰竭之间的相互作用。
JACC Clin Electrophysiol. 2022 Feb;8(2):194-196. doi: 10.1016/j.jacep.2021.10.009.
9
Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?心脏植入式电子设备在隐匿性心房颤动栓塞风险分层及管理中的作用：所有心房颤动都是一样的吗？
Expert Rev Cardiovasc Ther. 2018 Mar;16(3):175-181. doi: 10.1080/14779072.2018.1438267. Epub 2018 Feb 15.
10
Burden of Implanted-Device-Detected Atrial High-Rate Episode Is Associated With Future Heart Failure Events - Clinical Significance of Asymptomatic Atrial Fibrillation in Patients With Implantable Cardiac Electronic Devices.植入式设备检测到的心房高频事件负担与未来心力衰竭事件相关 - 植入式心脏电子设备患者无症状心房颤动的临床意义。
Circ J. 2019 Mar 25;83(4):736-742. doi: 10.1253/circj.CJ-18-1130. Epub 2019 Feb 26.
本文引用的文献
1
Risk of Atrial Fibrillation and Adverse Outcomes in Patients With Cardiac Implantable Electronic Devices.心脏植入式电子设备患者发生心房颤动及不良结局的风险
Korean Circ J. 2024 Jan;54(1):13-27. doi: 10.4070/kcj.2023.0084. Epub 2023 Sep 19.
2
Clinical Implications of Device-Detected Atrial Fibrillation in Cardiac Resynchronization Therapy.心脏再同步治疗中设备检测到的心房颤动的临床意义
Korean Circ J. 2023 Jul;53(7):483-496. doi: 10.4070/kcj.2022.0342. Epub 2023 May 2.
3
Association of Gender With Clinical Outcomes in a Contemporary Cohort of Patients With Atrial Fibrillation Receiving Oral Anticoagulants.当代接受口服抗凝剂治疗的房颤患者队列中性别与临床结局的关联
Korean Circ J. 2022 Aug;52(8):593-603. doi: 10.4070/kcj.2021.0399. Epub 2022 Apr 26.
4
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
5
Risk Factor Management for Atrial Fibrillation.心房颤动的危险因素管理
Korean Circ J. 2019 Sep;49(9):794-807. doi: 10.4070/kcj.2019.0212.
6
Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.装置检测到的心房颤动抗凝治疗的处方变化与结局的实践差异。
Circulation. 2019 May 28;139(22):2502-2512. doi: 10.1161/CIRCULATIONAHA.118.038988. Epub 2019 Mar 17.
7
Assessing the accuracy of an automated atrial fibrillation detection algorithm using smartphone technology: The iREAD Study.利用智能手机技术评估自动心房颤动检测算法的准确性：iREAD 研究。
Heart Rhythm. 2018 Oct;15(10):1561-1565. doi: 10.1016/j.hrthm.2018.06.037. Epub 2018 Aug 22.
8
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).设备检测到的亚临床房性快速心律失常：定义、影响及管理——一份欧洲心律协会（EHRA）共识文件，得到心律学会（HRS）、亚太心律学会（APHRS）和拉丁美洲心脏刺激与电生理学会（SOLEACE）认可
Europace. 2017 Sep 1;19(9):1556-1578. doi: 10.1093/europace/eux163.
9
Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study.使用 AliveCor 心脏监测仪进行远程心率采样以筛查心房颤动的评估：REHEARSE-AF 研究。
Circulation. 2017 Nov 7;136(19):1784-1794. doi: 10.1161/CIRCULATIONAHA.117.030583. Epub 2017 Aug 28.
10
The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort Data.韩国心房颤动相关住院就诊情况、费用、治疗模式及死亡率趋势：10年全国样本队列数据
Korean Circ J. 2017 Jan;47(1):56-64. doi: 10.4070/kcj.2016.0045. Epub 2016 Dec 26.
Zotero 插件